That price per share doesn't take into account any of the other countries, and only uses a P/E ratio of 15, when the biotech average is high 50. It will likely get over $1 this year in my opinion if everything pans out the way it is supposed to. Just my opinion. I didn't say I wasn't gonna sell any stock before it gets to $1.